Front. Pediatr.Frontiers in PediatricsFront. Pediatr.2296-2360Frontiers Media S.A.10.3389/fped.2021.783665PediatricsOriginal ResearchViral Coinfection and Nasal Cytokines in Children With Clinically Diagnosed Acute SinusitisLopezSantiago M. C.123†ShaikhNader3*†JohnsonMonika3LiuHui3MartinJudith M.3†WilliamsJohn V.3†1Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, United States2Sanford Research, Environmental Influences on Health and Disease Group, Sioux Falls, SD, United States3Department of Pediatrics, University of Pittsburgh School of Medicine, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, PA, United States
Edited by: Diego Raul Hijano, St. Jude Children's Research Hospital, United States
Reviewed by: Yutaka Yoshii, The Jikei University School of Medicine, Japan; Jordy Saravia, St. Jude Children's Research Hospital, United States
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Objective: Children with no pathogenic bacteria in the nasopharynx are unlikely to have acute bacterial sinusitis. We evaluated whether information on clinical presentation, viral co-detection, and mucosal cytokine levels could be used to predict presence of bacteria in the nasopharynx.
Method: We obtained nasopharyngeal (NP) swabs from children diagnosed with acute sinusitis. NP swabs were processed for bacterial culture, viral PCR testing, and cytokine expression. We examined whether results of the bacterial culture could be predicted based on the presence of clinical information, presence of viruses or mucosal cytokine levels.
Results: We enrolled 174 children; 123 (71%) had a positive culture for potentially pathogenic bacteria and 51 (29%) had normal flora. 122/174 (70%) tested positive for one or more viruses. Compared to children with normal flora, children with pathogenic bacteria were more likely to have viruses (p < 0.01), but this relationship disappeared when we adjusted for age. Children with pathogenic bacteria in their nasopharynx and children with normal flora had similar levels of nasal cytokines.
Conclusion: In children with clinically diagnosed acute sinusitis, clinical presentation, levels of nasal cytokines, and presence of viruses do not differentiate children with and without pathogenic bacteria in their nasopharynx.
sinusitisvirusmucosal immune responsecytokineschildrenTL1R001858U01AI118506National Institutes of Health10.13039/100000002Introduction
Acute sinusitis is one of the most common infections in childhood leading to antibiotic prescription (1, 2). Differentiation between acute sinusitis requiring antibiotics and an uncomplicated viral upper respiratory tract infection is currently based on the duration of upper respiratory tract symptoms. Thus, the tools to diagnose and manage this condition remain limited. Accordingly, if ancillary tests could differentiate children with bacterial acute sinusitis and children with an uncomplicated viral infection, unnecessary use of antimicrobials could be reduced. This is especially important since acute sinusitis is a leading cause of outpatient antimicrobial prescription (1–3).
Previous studies have shown that, for children with acute otitis media, which has very similar pathogens compared to acute sinusitis, when pathogens are absent from the nasopharynx, bacterial superinfection is highly unlikely (4–8). In this study, we aimed to investigate whether nasal cytokine levels, clinical presentation, or presence of viruses, which could in principle be performed as a point of care test, could predict nasopharyngeal bacterial culture, which takes several days to result.
MethodsParticipants
Subjects were children 2–12 years of age who were participants in an ongoing multicenter prospective clinical trial (www.ClinicalTrials.gov, study identifier: NCT02554383). We used stringent diagnostic criteria, defined a priori, consistent with the American Academy of Pediatrics guidelines (9). Eligible subjects had either: (1) persistent upper respiratory tract infection symptoms, i.e., 10–29 days of cough (not exclusively nocturnal) and/or nasal symptoms (rhinorrhea of any quality) which was not improving; or (2) worsening symptoms (substantial worsening of nasal symptoms and/or fever after a period of improvement). We excluded children who had: (1) severe presentation (9); (2) had received antimicrobial treatment within 15 days before presentation; (3) had evidence of another infection (i.e., acute otitis media or pneumonia); or (4) had underlying immune deficiency, cystic fibrosis, ciliary dyskinesia, or major developmental delay. The University of Pittsburgh Institutional Review Board approved the study and parents/guardians provided written consent.
At the time of diagnosis, we collected detailed information about the child's presenting symptoms (number of days with symptoms, fever, nasal discharge, daytime cough, asthma, seasonal allergies, local and systemic antihistamine use, exposure in school, and season of diagnosis). In addition, parents answered a previously published validated electronic measure of symptom severity [Pediatric Rhinosinusitis Symptoms Scale (PRSS)] (10).
Materials: Samples Collection, Microbiology, and Cytokines DataSpecimen Collection and Processing
We obtained a NP sample from one nostril using a sterile, flexible, thin, flocked swab (ESwab™ -comprises 1 mL of Liquid Amies medium and a FLOQswab™-, COPAN Diagnostics Inc.). The tip of the nose was raised, and the swab introduced gently along the floor of the nasal cavity, passing under the inferior turbinate until the pharyngeal wall was reached. Once the swab was in contact with the pharyngeal wall it was removed gently. The swab was processed and refrigerated at 2–8°C until transport to the laboratory on ice. On arrival to the microbiology laboratory, it was processed into several aliquots (11) for viral detection, semi-quantitative bacterial culture, and cytokine transcript levels.
Bacterial Identification
For bacterial culture, samples were plated on three types of media: trypticase soy agar, 5% sheep blood agar, and chocolate agar (Becton Dickinson). Cultures were incubated overnight at 37°C with 5% CO2. If no growth was present after overnight incubation, the culture was reincubated for another 24 h. Growth of pathogenic bacteria (Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis) was assessed using standard techniques (12).
Viral Identification
We performed individual real-time RT-PCR assays for the detection and subtyping of human rhinovirus (HRV), influenza subtypes A/B/C, adenovirus, human metapneumovirus (HMPV), parainfluenza virus (PIV) subtypes 1–4, and respiratory syncytial virus (RSV) using previously described methods (13–15). Negative and positive controls were included with each run and specimens were considered positive if the CT value was <40 cycles.
Cytokine Measurement
Nucleic acid extraction was performed with the ABI MagMax96 Express automated instrument. Gene expression of interleukin (IL)-6, IL-8, IL-10, IL-13, IL-17, IL-22, IL-25, IL-26, sIL22RA2, IL-33, interferon (IFN) α, β, γ, and λ was measured using exon-spanning primers and probes according to the manufacturer's instructions (TaqMan™, Applied Biosystems). All values were normalized to the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) housekeeping gene. Cytokines were grouped into three functional classifications based on published data: proinflammatory (IL-6, IL-8, IL-17, IL-22, IL-25, IL26, and IL-33), anti-inflammatory (IL-10, IL-13, and sIL22RA2) and antiviral (IFN-α, IFN-β, IFN-γ, and IFN-λ) (16–25). We normalized cytokine expression using the 2−ΔΔCT method (26), by enrolling 30 age-matched asymptomatic healthy controls who had no underlying medical conditions. We excluded children with fever or cold symptoms within the past 7 days; antimicrobial use in the last 14 days; or nasally administered medication in the last 15 days. There was no difference on the mean age, gender and viral detection of asymptomatic healthy controls compared with the study group. Further data regarding this group are not shown.
Data AnalysisStatistical Analysis
We used Kruskal-Wallis test for continuous variables and Chi-squared or Fisher's exact tests for categorical variables. Because 14 cytokines were tested, we used Benjamini-Hochberg correction to adjust p-values for multiple comparisons. For the multivariate analysis, we performed a logistic regression model with forward selection. Two-sided p < 0.05 were considered statistically significant throughout. All statistical analyses were performed using SAS 9.4 and R 3.6.2.
ResultsSubject Characteristics
We enrolled 174 children with clinically diagnosed AS. The median age of the children was 4.9 years [IQR: 3.5, 7.5]. A total of 123/174 (71%) had a positive bacterial culture for potentially pathogenic bacteria (i.e., Streptococcus pneumoniae, non-typeable Haemophilus influenzae, Moraxella catarrhalis). These children will hereinafter be referred to as being “colonized with bacteria.” A total of 51 (29%) children had growth of normal respiratory flora (hereinafter referred children with “normal flora”).
Compared to children with normal flora, children colonized with bacteria were younger (4.2 vs. 7.6 years, p < 0.01) and were more likely to be non-white (p = 0.03) (Table 1). We found no difference in gender or clinical presentation between two groups (Table 1). Among children colonized with bacteria, 71/123 (58%) were colonized with a single pathogen and 52 (42%) were colonized with >1 pathogen. The most frequently cultured bacteria was Moraxella catarrhalis (n = 79) (Figure 1).
Demographics and clinical characteristics of children with acute sinusitis.
Distribution of bacteria in 123 children with clinical diagnosis of acute sinusitis who had pathogens in their nasopharynx.
Viral Detection During Acute Sinusitis
A total of 122/174 (70%) children tested positive for at least one virus. Viruses (n = 95; 77%) were more likely to be detected in children colonized with bacteria than in those with normal flora (n = 27; 53%) (p < 0.01) (Figure 2); however, this association disappeared when we controlled for age (p = 0.06) (data not shown). Among those 122 children with virus(es), HRV was the most commonly detected virus (n = 81) followed by influenza virus (n = 18) and adenovirus (n = 18) (Figure 3). There were no significant differences in the cycle threshold values between groups (data not shown).
Number of viruses detected among children with acute sinusitis according to the presence of nasopharyngeal bacteria.
Individual viruses detected among children with acute sinusitis.
Cytokine Expression During Acute Sinusitis
We measured cytokine expression in 169 (97%) children, five children were excluded due to missing values on housekeeping protein (GAPDH). Cytokine mRNA levels were similar in children with normal flora and children colonized with bacteria (Table 2 and Supplementary Figure 1), and this remained the case in younger children (age ≤5 years old).
Normalized cytokine expression in children with acute sinusitis according presence of bacterial pathogens in the nasopharynx.
Common name
Gene name
Colonized with bacteria* (n = 118)
Normal flora (n = 51)
P-value**
Median [IQR]
Pro-inflammatory
IL-6
IL6
3.9 [1.5, 18.0]
1.7 [0.9, 7.8]
0.12
IL-8
CXCL8
6.8 [2.3, 25.5]
2.2 [0.8, 19.4]
0.26
IL-17
IL17A
0.6 [0.3, 1.4]
0.9 [0.3, 1.6]
0.46
IL-22
IL22
11.2 [1.6, 44.1]
7.5 [0.3, 30.6]
0.40
IL-25
IL25
0.6 [0.1, 3.8]
1.5 [0.4, 13.4]
0.18
IL-26
IL26
0.5 [0.2, 1.0]
0.6 [0.3, 1.3]
0.20
IL-33
IL33
0.6 [0.2, 1.1]
0.8 [0.4, 1.4]
0.40
Anti-inflammatory
IL-10
IL10
2.0 [0.9, 4.3]
1.4 [0.7, 4.5]
0.56
IL-13
IL13
0.7 [0.1, 6.3]
1.8 [0.2, 27.4]
0.12
sIL22-RA
IL22RA2
4.2 [1.6, 8.0]
2.8 [0.6, 7.6]
0.26
Antiviral
IFN-α
IFNA1
2.1 [0.7, 8.5]
3.6 [0.9, 9.7]
0.47
IFN-β
IFNB1
3.5 [1.1, 11.7]
6.2 [1.7, 14.7]
0.40
IFN-γ
IFNG
0.9 [0.5, 2.2]
1.1 [0.4, 2.6]
0.58
IFN-λ
IFNL1
1.6 [0.3, 79.2]
3.3 [0.3, 234.0]
0.47
IL, Interleukin; CXCL, chemokine (C-X-C motif) ligand; sIL22-RA, soluble receptor for IL-22; IFN, Interferon; IQR, interquartile range.
Five children excluded due to missing values on housekeeping protein (GAPDH).
P-values were adjusted for multiple comparisons using the Benjamini-Hochberg method.
Independent Predictors of Bacterial Presence
Multivariate analysis found that colonized children were younger than children with normal flora (p < 0.01) (data not shown).
Discussion
To our knowledge, this is the first study to characterize the presence of pathogens, viruses, and immune response in the nasopharynx at the time diagnosis of acute sinusitis in children. We found significant heterogeneity of bacteria isolated from the nasopharynx, with M. catarrhalis being the most common isolate. In addition, we identified viruses in a large proportion of children, with HRV being the predominant one. The initial insult for acute sinusitis is often a viral upper respiratory tract infection (9). We found that HRV was the most common virus detected during acute sinusitis, which is similar to other published data (27).
We found that viruses were more likely to be present in children colonized with bacterial pathogens (Figure 2). However, this difference was largely due to a difference in age in children with and without bacterial colonization; after controlling for age there was no significant association between viruses detected and presence of bacterial pathogens (p = 0.06).
Elevated levels of IL-1, IL-8, IL-6, and tumor necrosis factor-alpha (TNF-α) in nasal lavage fluid during acute viral upper respiratory tract infection have been reported (28, 29). Furthermore, a longitudinal study of 151 children with viral URI showed that elevated concentration of IL-6 correlated with fever and was significantly higher during influenza and adenovirus infection compared with enterovirus and HRV (30). IL-1 concentration was significantly higher in patients that later developed acute otitis media compared with subjects without acute otitis media (30). Unlike the above studies, nasal cytokine levels did not distinguish between children with and without bacterial colonization of the nasopharynx in this study. In addition, we found no difference on nasal cytokine levels between children using oral or topical antihistamine pre-enrollment (data not shown). Our findings describe an orchestrated immune response with overlapping proinflammatory and anti-inflammatory effects during acute sinusitis (Table 2). A better understanding of the host mucosal immune response could provide a basis for development of a novel diagnostic methodology.
Acute sinusitis is a clinical diagnosis based on stringent criteria with no ancillary test to aid the diagnosis (9). Differentiation between viral vs. bacterial infections can be challenging based on clinical presentation. To illustrate this, a recent longitudinal study found that 30% of patients with acute sinusitis had a new virus identified, with RSV the most common virus detected (31). Increasing availability of gene expression and transcriptional profiling could help with the diagnosis or management of acute sinusitis. A recent publication showed that host antiviral gene expression of CXCL10, CXCL 11, IFIT2, and OASL is associated with presence of respiratory viruses (32). Another showed the combination of tumor factor-related apoptosis-induced ligand (TRAIL), γ-induced protein-10 (IP-10), and C-reactive protein can differential bacterial infection from a viral process (33). Another group showed that IL-17, IL-4, IFN-γ, and INF-λ inducible protein-10 were associated with decreased risk of hospitalization during viral lower respiratory tract infection (29). Our cytokine expression results did not help differentiate between children with acute sinusitis who were colonized with pathogens and those who were not.
Our study has several limitations. Nasopharyngeal swabs are not routinely performed in clinical practice; however, we used this method as a research tool to evaluate its potential role in diagnosis. There was a statistically significant difference in the age between the children with and without bacterial colonization (Table 1). However, we found no differences in seasonality, clinical presentation, or disease severity between the groups. We excluded children with severe sinusitis presentation, but this is <5% of children with sinusitis (9). A strength of our study was inclusion of a large representative sample of children and development of a novel method of performing bacterial culture, viral detection, cytokine measurement using a single NP swab (11).
Conclusion
This study yields insight into the host's response to viruses and bacteria in the nasopharynx. Further exploration of these interactions may elucidate the contributions of each to the pathophysiology of acute sinusitis.
Data Availability Statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics Statement
The studies involving human participants were reviewed and approved by University of Pittsburgh Institutional Review Board. Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin.
Author Contributions
NS, SL, and HL are responsible for drafting the initial manuscript. NS, SL, JM, and JW are responsible for study concept and design, acquisition of data analysis and interpretation of data, and formal analysis. HL and MJ are responsible for acquisition of data and analysis and interpretation of data. All authors revised the manuscript, approved the final manuscript as submitted, and agree to be accountable for all aspects of the work.
Funding
This work was supported by NIH [U01AI118506]; www.clinicaltrials.gov, study identifier: [NCT02554383]. SL was supported by TL1 [TL1R001858]. JW was supported by the Henry L. Hillman Chair in Pediatric Immunology. This project was also supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number 5P20GM121341.
Conflict of Interest
JW serves on the Scientific Advisory Board of Quidel and ID Connect, and on an Independent Data Monitoring Committee for GlaxoSmithKline, none related to the present work. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fped.2021.783665/full#supplementary-material
ReferencesHaversFPHicksLAChungJRGaglaniMMurthyKZimmermanRK. Outpatient antibiotic prescribing for acute respiratory infections during influenza seasons. JAMA Netw Open. (2018) 1:e180243. 10.1001/jamanetworkopen.2018.024330646067PalmsDLHicksLABartocesMHershALZettsRHyunDY. Comparison of antibiotic prescribing in retail clinics, urgent care centers, emergency departments, and traditional ambulatory care settings in the United States. JAMA Intern Med. (2018) 178:1267–9. 10.1001/jamainternmed.2018.163230014128KingLMSanchezGVBartocesMHicksLAFleming-DutraKE. Antibiotic therapy duration in US adults with sinusitis. JAMA Intern Med. (2018) 178:992–4. 10.1001/jamainternmed.2018.040729582085CaseyJRKaurRFriedelVCPichicheroME. Acute otitis media otopathogens during 2008 to 2010 in Rochester, new york. Pediatr Infect Dis J. (2013) 32:805–9. 10.1097/INF.0b013e31828d9acc23860479FadenHStanievichJBrodskyLBernsteinJOgraPL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J. (1990) 9:623–6. 2122410GehannoPLenoirGBarryBBonsJBoucotIBercheP. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J. (1996) 15:329–32. 10.1097/00006454-199604000-000098866802EldanMLeibovitzEPiglanskyLRaizSPressJYagupskyP. Predictive value of pneumococcal nasopharyngeal cultures for the assessment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. (2000) 19:298–303. 10.1097/00006454-200004000-0000710783018SyrjanenRKHervaEEMakelaPHPuhakkaHJAuranenKJTakalaAK. The value of nasopharyngeal culture in predicting the etiology of acute otitis media in children less than two years of age. Pediatr Infect Dis J. (2006) 25:1032–6. 10.1097/01.inf.0000241097.37428.1d17072126WaldERApplegateKEBordleyCDarrowDHGlodeMPMarcySM. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. Pediatrics. (2013) 132:e262–80. 10.1542/peds.2013-107123796742ShaikhNWaldERJeongJHKurs-LaskyMNashDPichicheroME. Development and modification of an outcome measure to follow symptoms of children with sinusitis. J Pediatr. (2019) 207:103–8.e1. 10.1016/j.jpeds.2018.11.01630545562LopezSMCMartinJMJohnsonMKurs-LaskyMHorneWTMarshallCW. A method of processing nasopharyngeal swabs to enable multiple testing. Pediatric Res. (2019) 86:651–4. 10.1038/s41390-019-0498-131288247LeberAL (editor). Clinical Microbiology Procedure Handbook. Press WDA. Washington, DC: American Society for Microbiology. (2016).KlemencJAsad AliSJohnsonMTollefsonSJTalbotHKHartertTV. Real-time reverse transcriptase PCR assay for improved detection of human metapneumovirus. J Clin Virol. (2012) 54:371–5. 10.1016/j.jcv.2012.05.00522677006HallCBWeinbergGABlumkinAKEdwardsKMStaatMASchultzAF. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics. (2013) 132:e341–8. 10.1542/peds.2013-030323878043GrijalvaCGGriffinMREdwardsKMJohnsonMGilAIVerasteguiH. Concordance between RT-PCR-based detection of respiratory viruses from nasal swabs collected for viral testing and nasopharyngeal swabs collected for bacterial testing. J Clin Virol. (2014) 60:309–12. 10.1016/j.jcv.2014.04.01124875136DelvesPJMartinSJBurtonDRRoittIM. Roitt's essential immunology (2017).DivekarRKitaH. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol. (2015) 15:98–103. 10.1097/ACI.000000000000013325479313GuCWuLLiX. IL-17 family: cytokines, receptors and signaling. Cytokine. (2013) 64:477–85. 10.1016/j.cyto.2013.07.02224011563LaurenceAO'SheaJJWatfordWT. Interleukin-22: a sheep in wolf's clothing. Nat Med. (2008) 14:247–9. 10.1038/nm0308-24718323844LeeMKimDWShinHW. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps. Curr Opin Allergy Clin Immunol. (2017) 17:17–22. 10.1097/ACI.000000000000033227870664OuyangWRutzSCrellinNKValdezPAHymowitzSG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. (2011) 29:71–109. 10.1146/annurev-immunol-031210-10131221166540RutzSWangXOuyangW. The IL-20 subfamily of cytokines–from host defence to tissue homeostasis. Nat Rev Immunol. (2014) 14:783–95. 10.1038/nri376625421700SaadounDTerrierBCacoubP. Interleukin-25: key regulator of inflammatory and autoimmune diseases. Curr Pharm Des. (2011) 17:3781–5. 10.2174/13816121179835787222103849TengvallSCheKFLindenA. Interleukin-26: an emerging player in host defense and inflammation. J Innate Immun. (2016) 8:15–22. 10.1159/00043464626202572WynnTA. IL-13 effector functions. Annu Rev Immunol. (2003) 21:425–56. 10.1146/annurev.immunol.21.120601.14114212615888LivakKJSchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. (2001) 25:402–8. 10.1006/meth.2001.126211846609DeMuriGPGernJEMoyerSCLindstromMJLynchSVWaldER. Clinical features, virus identification, and sinusitis as a complication of upper respiratory tract illness in children ages 4–7 years. J Pediatr. (2016) 171:133–9 e1. 10.1016/j.jpeds.2015.12.03426787374NoahTLHendersonFWWortmanIADevlinRBHandyJKorenHS. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. (1995) 171:584–92. 10.1093/infdis/171.3.5847876605NicholsonEGSchlegelCGarofaloRPMehtaRSchefflerMMeiM. Robust cytokine and chemokine response in nasopharyngeal secretions: association with decreased severity in children with physician diagnosed bronchiolitis. J Infect Dis. (2016) 214:649–55. 10.1093/infdis/jiw19127190183PatelJANairSRevaiKGradyJChonmaitreeT. Nasopharyngeal acute phase cytokines in viral upper respiratory infection: impact on acute otitis media in children. Pediatr Infect Dis J. (2009) 28:1002–7. 10.1097/INF.0b013e3181aa5b1319859015DeMuriGPEickhoffJCGernJCWaldER. Clinical and virological characteristics of acute sinusitis in children. Clin Infect Dis. (2019) 69:1764–70. 10.1093/cid/ciz02330649261LandryMLFoxmanEF. Antiviral response in the nasopharynx identifies patients with respiratory virus infection. J Infect Dis. (2018) 217:897–905. 10.1093/infdis/jix64829281100SrugoIKleinASteinMGolan-ShanyOKeremNChistyakovI. Validation of a novel assay to distinguish bacterial and viral infections. Pediatrics. (2017) 140:e20163453. 10.1542/peds.2016-345328904072